跳至主要内容
临床试验/JPRN-UMIN000048540
JPRN-UMIN000048540已完成未知

Clinical pharmacology study of calcium alginate capsules -optimization study of inhibition of postprandial blood glucose level elevation- - Postprandial blood glucose elevation inhibitory effect optimization test of calcium alginate capsules

Takasaki University of Health and Welfare0 个研究点目标入组 21 人开始时间: 2022年8月10日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Persons whose BMI and body weight do not fit into the normal distribution (95% confidence interval) 2.Persons taking medicines or supplements that may affect glucose metabolism 3.Persons who are currently being treated for diabetes or who are judged to need treatment 4.Persons with serious diseases such as diabetes, liver disease, renal disease, hypertension, ischemic heart disease, digestive system disease, and those with a history of them 5.Persons who may cause allergic symptoms regarding udon noodles (flour, etc.)

研究者

相似试验

Clinical pharmacology study of calcium alginate... | 临床试验